FDA Restricts COVID-19 Vaccine Access To High-Risk Groups.
Digest more
FDA announces cucumber recall
Digest more
The FDA warns that longtime users of popular allergy medications may experience "severe itching" after stopping use.
The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to halt the sale and production of off-brand products that many patients in the United States have come to rely on.
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are healthy
Explore more
The programmed death receptor-1-blocking antibody is approved as a single agent or in combination with chemotherapy
The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under age 65, effectively limiting them to older adults and those at risk of developing severe illness.
The agency will require manufacturers to add a warning to prescription and OTC labeling about the risk of itching and the potential to resolve it by restarting the medication.
The Food and Drug Administration (FDA) announced Wednesday plans to help states and Indian tribes import cheaper prescription drugs from Canada. The initiative is in support of President Donald Trump’s executive order on May 12 which promised to deliver “most-favored nation prescription drug pricing” to America,
Johnson & Johnson has won the support of an FDA expert panel in its bid to make Darzalex the first treatment for an early form of multiple myeloma despite uncertainties raised by regulators.